Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Potential of equine herpesvirus 1 as a vector for immunization.

Trapp S, von Einem J, Hofmann H, Köstler J, Wild J, Wagner R, Beer M, Osterrieder N.

J Virol. 2005 May;79(9):5445-54.

2.

Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines.

Hofmann-Sieber H, Wild J, Fiedler N, Tischer K, von Einem J, Osterrieder N, Hofmann H, Köstler J, Wagner R.

J Virol. 2010 Nov;84(22):11602-13. doi: 10.1128/JVI.00677-10. Epub 2010 Sep 8.

3.

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

Osterrieder N, Wagner R, Brandmüller C, Schmidt P, Wolf H, Kaaden OR.

Virology. 1995 Apr 20;208(2):500-10.

4.

Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses.

Qiu JT, Song R, Dettenhofer M, Tian C, August T, Felber BK, Pavlakis GN, Yu XF.

J Virol. 1999 Nov;73(11):9145-52.

5.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.

6.
8.

Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD.

Zhang Y, Smith PM, Tarbet EB, Osterrieder N, Jennings SR, O'Callaghan DJ.

Virus Res. 1998 Jul;56(1):11-24.

PMID:
9784062
9.

A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.

Van de Walle GR, May MA, Peters ST, Metzger SM, Rosas CT, Osterrieder N.

Vaccine. 2010 Jan 22;28(4):1048-55. doi: 10.1016/j.vaccine.2009.10.123. Epub 2009 Nov 6.

PMID:
19897066
10.

Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.

Ellis JA, Steeves E, Wright AK, Bogdan JR, Davis WC, Kanara EW, Haines DM.

Vet Immunol Immunopathol. 1997 Jul;57(3-4):201-14.

PMID:
9261959
11.

Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.

Chikhlikar P, Barros de Arruda L, Agrawal S, Byrne B, Guggino W, August JT, Marques ET Jr.

Virology. 2004 Jun 1;323(2):220-32.

12.
13.

Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity.

Steinbach F, Borchers K, Ricciardi-Castagnoli P, Ludwig H, Stingl G, Elbe-Bürger A.

J Gen Virol. 1998 Dec;79 ( Pt 12):3005-14.

PMID:
9880015
14.

Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.

Tewari D, Nair SV, De Ungria MC, Lawrence GL, Hayden M, Love DN, Field HJ, Whalley JM.

Arch Virol. 1995;140(4):789-97.

PMID:
7794119
16.

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and gpE2 and nonstructural proteins 3, 4, and 5.

Lin Y, Kwon T, Polo J, Zhu YF, Coates S, Crawford K, Dong C, Wininger M, Hall J, Selby M, Coit D, Medina-Selby A, McCoin C, Ng P, Drane D, Chien D, Han J, Vajdy M, Houghton M.

J Virol. 2008 Aug;82(15):7492-503. doi: 10.1128/JVI.02743-07. Epub 2008 May 28.

17.

Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies.

Moriya C, Horiba S, Kurihara K, Kamada T, Takahara Y, Inoue M, Iida A, Hara H, Shu T, Hasegawa M, Matano T.

Vaccine. 2011 Nov 3;29(47):8557-63. doi: 10.1016/j.vaccine.2011.09.028. Epub 2011 Sep 20.

PMID:
21939708
18.

Kunjin virus replicon vectors for human immunodeficiency virus vaccine development.

Harvey TJ, Anraku I, Linedale R, Harrich D, Mackenzie J, Suhrbier A, Khromykh AA.

J Virol. 2003 Jul;77(14):7796-803.

19.

Potential of DNA-mediated vaccination for equine herpesvirus 1.

Ruitenberg KM, Walker C, Wellington JE, Love DN, Whalley JM.

Vet Microbiol. 1999 Aug 16;68(1-2):35-48.

PMID:
10501160

Supplemental Content

Support Center